期刊文献+

美托洛尔治疗慢性充血性心力衰竭临床疗效观察 被引量:5

Curative Observation of Treatment on Chronic Congestive Heart Failure with Metoprolol
下载PDF
导出
摘要 目的:观察美托洛尔治疗慢性充血性心力衰竭的临床疗效。方法治疗组60例慢性充血性心力衰竭患者在常规治疗基础上加服美托洛尔,初始剂量为6.25mgBidpo;对照组60例慢性充血性心力衰竭患者单用常规治疗;疗程为4周。心功能改善Ⅱ级或以上为显效;心功能改善Ⅰ级为有效;无变化或恶化为无效。结果治疗组显效41例(显效率68.9%),有效11例,总有效率88%,无效8例占(12%);对照组显效24例(显效率40%),有效18例,总有效率70%:无效18例占30%。两组比较总有效率有差异显著(P<0.05)。结论治疗慢性充血性心力衰竭,加用美托洛尔能显著提高临床疗效。 Objective:Abstrast. Objective Curative Value of Treatment on Chronic Congestive Heart Failure with Metoprolol. Methods. 60 cases of Chronic Congestive Heart Failure with common practice and Metoprolol 6.25mg ( the first time), Bid po for 4 weeks; Control group, 60 cases of Chronic Congestive Heart Failure with common practice only , for 4weeks; Observe improve degree of. Heart Failure. Results. The tolal effective rate was 88% in observe group and 70% in control group. Conclusion Treatment on Congestive Heart Failure increasing with Metoprolol is better than with common practice only.
作者 金顺实
出处 《中国伤残医学》 2009年第4期32-33,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 美托洛尔 治疗 慢性充血性心力衰竭 Metoprolol, Treatment, Chronic Congestive Heart Failure
  • 相关文献

参考文献4

二级参考文献23

  • 11,Gavg R,Yusuf S.Overview of randomized trial of angiotensin -converting enzyme inhibitors on mortality and morbidity in patients with heart failure.Collaborative Group on ACE inhibitors.JAMA,1995;273(18):1450
  • 22,CIBIS-Ⅱ Investigators and Committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ)a randomised trial.Lancet,1999;353(9146):9
  • 33,MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure(MERIT-HF).Lancet,1999;353(9169):2001
  • 4Hori M, Sasayama S, Kitabatake A, et al. MUCHA Investigators. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose
  • 5Pitt B, Jr CT, Rajagopalan S. Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease. J Renin Angiotensin Aldosterone Syst. 2003,4:164-168
  • 6Moore TD, Nawarskas JJ, Anderson JR. Eplerenone a selective aldosterone receptor antagonist for hypertension and heart failure. Heart Dis. 2003,5:354-363
  • 7Cleland JG. Beta-blockers for heart failure: why, which, when, and where. Med Clin North Am. 2003,87:339
  • 8The SOLVD investigators: Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 1991,325:293
  • 9The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enanapril survival study. New Engl J Med. 1987,316:1429
  • 10Eichhorn ET and Gheorghiade M. Digoxin. Progr cardiovasc Dis, 2002,44:251

共引文献293

同被引文献28

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部